THEME 4: MARINE BIOLOGICAL RESOURCES  – BIOTECHNOLOGY

Selachians are a type of fish whose origins date back 400 million years. The study of certain of their characteristics will make it possible to identify new bio-active peptides which the companies and laboratories investing in the SEALACIAN project predict will possess anti-cancer and anti-infection properties.

The small businesses and laboratories engaged in this research are all sharing their skills and facilities. Over and above production of new therapeutic molecules, the SEALACIAN project will lead to an advance in scientific knowledge and a broadening of the services offered by the two industrial partners.


SEALACIAN PROJECT PARTNERS

Companies 

• C.RIS Pharma in Saint-Malo is piloting the project. This company specialises in the pre-clinical development and characterisation of new molecules with a pharmaceutical application, focusing on peptides in particular.
• Innova Proteomics in Rennes undertakes high-speed proteomic analyses to identify and isolate new peptides.

Research centres 

• Laboratoire PE2M, Université de Caen, is the Marine Molluscs Physiology and Ecophysiology
• Lab linked to UMR 100 of IFREMER and it carries out tissue sampling and analysis.
• L’ENSCR, Ecole nationale supérieure de Chimie de Rennes (National Advanced Institute of Chemistry in Rennes) has a technical facility specially adapted for the vectorisation of molecules.

Contacts

philippe.potin@pole-mer-bretagne.com
christine.bodeau@pole-mer-bretagne.com
eric.deslandes@pole-mer-bretagne.com